Lacosamide Oral Solution 10mg/ml (EU CTD Available: Q2 2022)

Product description

Lacosamide 10mg/ml Oral Solution
Reference Product: Vimpat® / UCB Description: Lacosamide is a functionalised amino acid which belongs to the group of antiepileptics. Lacosamide is used as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Dossier Status: On-going / EU CTD Available: Q2 2022
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Three (3) years
Batch Sizes: 970 Bottles
Pack Sizes: BT x 1 Glass Bottle
Read more

Specifications

Categories Pharmaceutical Products / ATC codingNervous System; Finished Dosage FormsOut-licensing
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Greece

More products from ANFARM HELLAS S.A.

View all our products (37)
Lacosamide Oral Solution 10mg/ml (EU CTD Available: Q2 2022)

Contact information

Address

Telephone

Website

View all contact information
CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Lonza

Lonza

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Elevate your expectations. Demand more from your CDMO.

Elevate your expectations. Demand more from your CDMO.

CONTENT GROUP

CONTENT GROUP